drugset / Trial / NCT00595946

Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone

NCT00595946

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary purpose of this study is to evaluate the efficacy and safety of lubiprostone administration in patients with Opioid-induced Bowel Dysfunction.

Timeline

Start
2007-08
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lubiprostone Small molecule 24 ug Oral